These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 9533475

  • 1. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
    Stout JE, Arnold B, Yu VL.
    J Antimicrob Chemother; 1998 Feb; 41(2):289-91. PubMed ID: 9533475
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro activity of macrolides against intracellular Legionella pneumophila.
    Segreti J, Meyer P, Kapell K.
    Diagn Microbiol Infect Dis; 1996 Jul; 25(3):123-6. PubMed ID: 8902407
    [Abstract] [Full Text] [Related]

  • 4. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.
    Visalli MA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1867-70. PubMed ID: 9303375
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella species.
    Johnson DM, Erwin ME, Barrett MS, Gooding BB, Jones RN.
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):751-5. PubMed ID: 1425738
    [Abstract] [Full Text] [Related]

  • 7. Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila.
    Jung R, Danziger LH, Pendland SL.
    J Antimicrob Chemother; 2002 May; 49(5):857-61. PubMed ID: 12003984
    [Abstract] [Full Text] [Related]

  • 8. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.
    Stout JE, Sens K, Mietzner S, Obman A, Yu VL.
    Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309
    [Abstract] [Full Text] [Related]

  • 9. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
    Nakashio S, Iwasawa H, Iino S, Shimada J.
    Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
    Felmingham D, Robbins MJ, Sanghrajka M, Leakey A, Ridgway GL.
    Drugs Exp Clin Res; 1991 Oct; 17(2):91-9. PubMed ID: 1650694
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
    Van Asselt GJ, Sloos JH, Mouton RP, Van Boven CP, Van de Klundert JA.
    J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
    [Abstract] [Full Text] [Related]

  • 13. [Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila].
    Yu LL, Hu BJ, Huang SL, Zhou ZY, Tao LL.
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):409-12. PubMed ID: 21781510
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of quinupristin/dalfopristin (Synercid, RP 59500) against Legionella spp.
    Edelstein PH, Edelstein MA.
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):49-52. PubMed ID: 10744367
    [Abstract] [Full Text] [Related]

  • 15. Review of azithromycin activity against Legionella spp.
    Edelstein PH.
    Pathol Biol (Paris); 1995 Jun; 43(6):569-72. PubMed ID: 8539085
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species.
    Higa F, Akamine M, Haranaga S, Tohyama M, Shinzato T, Tateyama M, Koide M, Saito A, Fujita J.
    J Antimicrob Chemother; 2005 Dec; 56(6):1053-7. PubMed ID: 16260445
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.
    Pendland SL, Martin SJ, Chen C, Schreckenberger PC, Danziger LH.
    J Clin Microbiol; 1997 Nov; 35(11):3004-6. PubMed ID: 9350781
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.